Business Wire

Torq Becomes the Cursor of Security Operations With New Agentic Builder

18.3.2026 14:00:00 CET | Business Wire | Press release

Share

Torq Transforms Human Intent Into Agentic Outcomes With Contextual Analysis, Planning, Building, and Testing That Delivers Production-Grade AI Agents in Minutes

Torq, the established agentic security operations leader, today unveiled Agentic Builder, a critical extension of the Torq AI SOC Platform that turns human intent into agentic outcomes. Agentic Builder enables SOCs to shift the cognitive load of engineering security automation from humans to machines. These Cursor-level capabilities eliminate all barriers to deliver production-grade agentic workflows and AI Agents that manage unlimited alerts 24x7, integrate with every level of the enterprise stack, streamline investigation, and respond at machine speed.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318328878/en/

This news follows Torq’s recent announcement that it has secured a $140M Series D round at $1.2B valuation to lead the AI SOC and Agentic AI era. Torq AI Agents are now deeply embedded in the daily operations of Fortune 500 SOCs, managing millions of complex security tasks autonomously. Torq now protects hundreds of multinational enterprises, including new customers LEGO, Marriott, and Prudential, who join the ranks of Carvana, PepsiCo, Procter & Gamble, Siemens, Uber, Virgin Atlantic, and countless others.

"After successfully delivering AI capabilities that have freed SOC analysts from overwhelming alerts, false positives, and fatigue, Torq now liberates SecOps engineers and architects from the manual tedium that delays value realization,” said Ofer Smadari, CEO and co-founder, Torq. “It eliminates the historic tradeoff between speed and control by enabling teams to design and operationalize sophisticated AI-driven security workflows through specific intent. What once took months of engineering and endless maintenance can now be realized in minutes, with built-in validation, governance, and continuous learning. It’s a fundamental redesign of how security operations are conceived, built, and scaled. Torq is ensuring defenders move faster than attackers—autonomously, intelligently, and without limits.”

Agentic Builder, designed from the ground up to dramatically elevate engineer and architect productivity, underscores how Torq continues to drive the complete transformation of the Security Operations Center (SOC) through the Torq AI SOC Platform. It’s the only end-to-end solution built on the pillars of advanced Hyperautomation, alert triage, and fatigue reduction to deliver full operational autonomy for global enterprises and government agencies.

Agentic Builder is part of Torq Socrates, the core orchestrator of the Torq AI SOC Platform, coordinating specialized AI agents to autonomously run security operations at scale through a natural language interface that accelerates security operations, decision making, and execution. Torq Socrates now provides that same machine speed and precision to SecOps engineers and architects, killing off the grunt work of manual planning, building, troubleshooting, and maintaining complex workflows and AI Agents.

“I’ve had a chance to preview Agentic Builder and it’s clear this will fundamentally change how SecOps works for the better,” said Corey Kaemming, CISO, Valvoline. “Agentic Builder feels less like configuring an application and more like collaborating with an intelligent counterpart that understands SecOps objectives, architects the best approach, and delivers a ready-to-run agent without manual rework and hassle. Instead of dedicating staff to stitching together integrations and debugging logic, Agentic Builder will enable organizations to redirect that expertise toward risk strategy and resilience. This is the kind of breakthrough that resets expectations for what a modern cyber defense program can achieve.”

Here’s how Agentic Builder works:

  • Security professionals describe the intent of any security outcome in natural language, which then prompts Agentic Builder to address anticipated security events, as well as ensuring the correct semantic memory, business context, organizational security standards, and tools are implemented
  • Agentic AI plans the assignment based on previous agentic workflows, selects the tools and integrations, defines the parameters and guardrails, implements the orchestration logic, and generates custom Torq AI Agents
  • Prior to deploying the new Torq AI Agent, Torq Socrates comprehensively tests it against real-world data, illustrates step-by-step actions and outputs, and validates potential results—such as email previews, case descriptions, and UI screens—which allows security professionals to refine behavior until it precisely matches organizational standards
  • Torq Socrates continuously monitors the execution of the new Torq AI Agents and agentic workflows in production, and auto-calibrates to improve resilience, performance, and adjust due to changing conditions

Torq is providing exclusive demos of Agentic Builder for qualified RSAC attendees, March 23-26, at Booth #527, South Expo Hall, Moscone Center in San Francisco.

About Torq

Torq is transforming cybersecurity with the Torq AI SOC Platform. Torq empowers enterprises to instantly and precisely detect and respond to security events at scale. Torq’s customer base includes major multinational enterprise customers, including Abnormal Security, Armis, Check Point Security, Chipotle Mexican Grill, Inditex (Zara, Bershka, and Pull & Bear), Informatica, Kyocera, PepsiCo, Procter & Gamble, Siemens, Telefónica, Valvoline, Virgin Atlantic, and Wiz.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260318328878/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse

Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye